Phase
Condition
High Cholesterol (Hyperlipidemia)
Diabetes Prevention
Chest Pain
Treatment
Hyperpolarized 13C-pyruvate
Clinical Study ID
Ages 21-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Healthy Volunteers:
Age 21 years and above
No significant medical co-morbidities (such as chronic kidney disease, diabetesmellitus, heart failure, ischemic heart disease, previous strokes)
No history of cancer
Able and willing to comply with study procedures and provide signed informed consent
Patients with cardiovascular/cardiometabolic diseases:
Age 21 years and above
Physician diagnosed cardiovascular conditions: ischemic heart disease, inheritedcardiomyopathies (hypertrophic, dilated or infiltrative cardiomyopathies) and stableheart failure; and/or
Cardiometabolic conditions (such as diabetes on medications, hypertension, centralobesity, fatty liver disease)
Able and willing to comply with study procedures and provide signed informed consent
Exclusion
Exclusion Criteria:
Standard contraindications for magnetic resonance procedures (such as implantablemedical devices, suspected presence of surgical apparatus or shrapnel, severeclaustrophobia)
Unstable medical conditions (such as symptomatic heart failure, unstablehypertension/glucose levels as determined by investigators, symptomatic arrhythmias,angina)
Pregnant or nursing women
Known allergies to pyruvate or any of its components
Study Design
Study Description
Connect with a study center
National Heart Centre Singapore
Singapore, 169609
SingaporeActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.